Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMears Regulatory News (MER)

Share Price Information for Mears (MER)

Share Price is delayed by 15 minutes
Get Live Data
409.00    -13.00 (-3.08%)
Bid:
410.00
Ask:
411.00
Spread: 1.00 (0.244%)
Market Cap: £327.83m
MER Live PriceLast checked at - London Stock Exchange

Intraday Mears Share Chart

Holding(s) in Company

7 Apr 2010 10:23

RNS Number : 8116J
Mears Group PLC
07 April 2010
 



 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii

Mears Group PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

NO

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

NO

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

NO

An event changing the breakdown of voting rights

NO

Other (please specify):

Fall below 3% on the basis of information disclosed by the issuer in its monthly total voting rights disclosure.

YES

3. Full name of person(s) subject to the notification obligation: iii

Breeden European Ventures LLC (Indirect)

 

4. Full name of shareholder(s)  (if different from 3.):iv

Breeden European Partners (California) L.P. (direct)

5. Date of the transaction and date on which the threshold is crossed or reached: v

31 March 2010

6. Date on which issuer notified:

6 April 2010

7. Threshold(s) that is/are crossed or reached: vi, vii

below 3%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

ORD

GB0005630420

below 3%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

below 3%

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

 

Less than 3% are held by Breeden European Partners (California) L.P.; a Limited Partnership, whose General Partner is Breeden European Capital Partners LLC, whose managing member is Richard C. Breeden & Co International LLC, whose managing member is Richard C. Breeden (Indirect Interests).

 

Breeden European Ventures LLC whose managing member is Richard C. Breeden has an indirect interest in the voting rights of less than 3% in its capacity as discretionary investment manager of Breeden European Partners (California) L.P.

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

14. Contact name:

Nandita Hogan. Breeden European Ventures LLC or alternatively Ben Barnett, Breeden European Capital Management LLP

15. Contact telephone number:

 +1 (203) 618-0065 or alternatively, +44 (0) 203 170 5518

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLIFFASLIDIII
Date   Source Headline
15th Jun 20265:12 pmRNSHolding(s) in Company
15th Jun 20267:00 amRNSTransaction in Own Shares
9th Jun 20269:02 amRNSDirector/PDMR Shareholding
8th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20262:05 pmRNSResult of AGM
1st Jun 202612:18 pmRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
26th May 202610:19 amRNSDirector/PDMR Shareholding
26th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSThurrock Council - £240m Contract Award
18th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:01 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
11th May 20263:03 pmRNSHolding(s) in Company
11th May 20269:02 amRNSExercise of options and PDMR dealing
1st May 202610:51 amRNSTotal Voting Rights
29th Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20268:42 amRNSMoat Homes £200m contract award
17th Apr 20263:43 pmRNSAnnual Financial Report
15th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20263:01 pmRNSGrant of Deferred Bonus Share Plan awards
8th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSLaunch of Share Buyback Programme of up to £20m
27th Mar 20269:37 amRNSDividend Declaration
26th Mar 20267:00 amRNSPreliminary Results
3rd Mar 20267:00 amRNSDisposal of non-core operation
2nd Mar 20263:36 pmRNSTotal Voting Rights
25th Feb 20262:03 pmRNSBoard appointment
28th Jan 20267:00 amRNSContract Award
22nd Jan 20267:00 amRNSPre-Close Trading Update
5th Jan 20267:00 amRNSBoard change – Employee Director
8th Dec 20257:00 amRNSTrading Update
15th Sep 20257:00 amRNSHolding(s) in Company
15th Sep 20257:00 amRNSAcquisition
12th Sep 20255:25 pmRNSHolding(s) in Company
29th Aug 202510:04 amRNSDirector/PDMR Shareholding
11th Aug 20257:00 amRNSDirector/PDMR Shareholding
7th Aug 20257:00 amRNSInterim Results
1st Aug 20259:44 amRNSDirectorship
24th Jun 20257:00 amRNSTrading Update
19th Jun 20254:53 pmRNSBlock Listing Application
16th Jun 20253:20 pmRNSBlock listing Interim Review
4th Jun 202510:55 amRNSResult of AGM
30th May 20254:08 pmRNSTotal Voting Rights
8th May 20255:40 pmRNSExercise of options and PDMR dealing
1st May 20257:00 amRNSContract Award
28th Apr 20254:02 pmRNSAnnual Financial Report 2024 and Notice of AGM
23rd Apr 20254:31 pmRNSGrant of Long-Term Incentive Plan awards
23rd Apr 20254:29 pmRNSGrant of Deferred Bonus Share Plan awards

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.